How to verify the prescriber and the telehealth company behind a compounded GLP-1 offer

A compounded GLP-1 program has three parties: the company whose name is on the website, the prescriber who signs the prescription, and the pharmacy that fills it. The website company is usually neither of the other two. Verifying the pharmacy is on its own page. This page is the other two.

The prescriber

Step 1: get the name and credential. Full name and the letters after it: MD, DO, NP, PA, or in some states PharmD with prescriptive authority. The program should tell you this before or at the consultation, and it must appear on the prescription and the dispensed label.

Step 2: NPI Registry. Search the name at npiregistry.cms.hhs.gov. The record shows the provider's name, NPI number, taxonomy (specialty), practice address and, for individuals, the state of the licence they entered. It confirms the person exists as a US healthcare provider. It does not confirm the licence is active; NPI records are not disciplinary records.

Step 3: the licensing board in your state. Search the medical board (MD, DO), the nursing board (NP), or the medical or PA board (PA) of the state where you are located during the consultation. Confirm the licence, registration or compact privilege is active and read the disciplinary section. If the prescriber holds no authorisation in your state, ask the program how the prescription is lawful; the answer may be a telehealth registration the board can confirm, or it may be nothing.

Step 4: the consultation itself. A prescriber who never learned your medical history could not have made the patient-specific determination that what compounders may do now describes. An intake that asks about current medicines, pregnancy, thyroid cancer history, pancreatitis and prior GLP-1 use is the minimum. One that asks for a weight and a card number is a checkout page.

The telehealth company

Find out what it legally is. Typical structures:

• A marketing and technology company that contracts with a medical group (which employs the prescribers) and a pharmacy (which dispenses). The brand you see does none of the regulated work. Ask for the medical group's name and the pharmacy's name.
• A medical practice that employs or contracts prescribers directly and sends prescriptions to an outside pharmacy. Licensed as a practice in some states; ask which.
• A pharmacy that also runs a telehealth front end. Less common; the pharmacy licence covers dispensing but not prescribing, so there is still a medical group somewhere.

FDA's March 3, 2026 press release on letters to 30 telehealth companies described exactly the problem this creates: products branded with the telehealth firm's own name or trademark, without qualification, so a customer could not tell who compounded the drug. The September 9, 2025 letters to online sellers cited claims that compounded products were the same as approved ones. Both are on the enforcement timeline.

Questions to put in writing

1. Who is the prescriber, what is their credential, and in which state are they authorised to treat me?
2. Which medical group employs or contracts them?
3. Which pharmacy will dispense, where is it, and is it a 503A pharmacy or a 503B outsourcing facility?
4. Will I receive a copy of the prescription and will the label name the prescriber and pharmacy?
5. If I stop paying, what happens to the prescription and any remaining refills?

The vetting checklist includes these when you tell it the offer is a telehealth program. How FormBlends itself answers them is on its regulatory status page; hold it to the same list.